CONFIDENCE: Real-world effectiveness of ocrelizumab in relapsing MS over 18 months

Young Investigator

Julius Eggebrecht

Roche Pharma AG

25

Grenzach-Wyhlen, Germany

Downloads

25 ECF2021 Abstract CL Eggebrecht J ( 85 KB, pdf)

25 ECF2021 Poster CL Eggebrecht J ( 120 KB, pdf)